These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22308751)

  • 1. [AntiEBV activity of 6-azacytidine and its derivatives].
    Zagorodniaia SD; Nesterova NV; Golovan' AV; Alekseeva IV; Palchikovs'kaia LI; Baranova GV
    Mikrobiol Z; 2011; 73(6):41-9. PubMed ID: 22308751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoquinone efficiently inhibits the survival of EBV-infected B cells and alters EBV gene expression.
    Zihlif MA; Mahmoud IS; Ghanim MT; Zreikat MS; Alrabadi N; Imraish A; Odeh F; Abbas MA; Ismail SI
    Integr Cancer Ther; 2013 May; 12(3):257-63. PubMed ID: 23089554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of isonicotinic acid derivates on reproduction of Epstein-Barr virus].
    Zahorodnia SD; Nesterova NV; Danylenko VP; Bukhtiarova TA; Baranova HV; Holovan' AV
    Mikrobiol Z; 2011; 73(2):65-72. PubMed ID: 21598662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin induces lytic cytotoxicity in Epstein-Barr virus-positive cells.
    Liu SF; Wang H; Li ZJ; Deng XY; Xiang H; Tao YG; Li W; Tang M; Cao Y
    Eur J Pharmacol; 2008 Jul; 589(1-3):8-13. PubMed ID: 18571159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Pinus massoniana Lamb. bark extract on lytic cycle of Epstein-Barr virus.
    Xu S; Zhang S; Wang X; Gao Y; Qin X; Wu K
    Indian J Exp Biol; 2012 Oct; 50(10):708-13. PubMed ID: 23214264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.
    Ballout M; Germi R; Fafi-Kremer S; Guimet J; Barguès G; Seigneurin JM; Morand P
    J Virol Methods; 2007 Jul; 143(1):38-44. PubMed ID: 17368820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of Epstein-Barr virus reproduction--ribonucleosides of 3-substituted 1,2,4-triazino[5,6-b] [1,4] benzothiasines.
    Golovan AJ; Nesterova NV; Zagorodnya SD; Alexeeva LV; Palchykovska LI; Usenko LS; Baranova GV
    Mikrobiol Z; 2010; 72(2):36-42. PubMed ID: 20455440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral response to chemotherapy in endemic burkitt lymphoma.
    Tang W; Harmon P; Gulley ML; Mwansambo C; Kazembe PN; Martinson F; Wokocha C; Kenney SC; Hoffman I; Sigel C; Maygarden S; Hoffman M; Shores C
    Clin Cancer Res; 2010 Apr; 16(7):2055-64. PubMed ID: 20233888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.
    Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK
    Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of proteflazid on the Epschtein-Barr virus].
    Zagorodniaia SD; Golovan' AV; Baranova GV; Nesterova NV
    Mikrobiol Z; 2009; 71(1):57-61. PubMed ID: 19663329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus.
    Junker AK
    Pediatr Rev; 2005 Mar; 26(3):79-85. PubMed ID: 15743754
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
    Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers.
    Hoshino Y; Katano H; Zou P; Hohman P; Marques A; Tyring SK; Follmann D; Cohen JI
    J Virol; 2009 Nov; 83(22):11857-61. PubMed ID: 19740997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells.
    Rao SP; Rechsteiner MP; Berger C; Sigrist JA; Nadal D; Bernasconi M
    Mol Cancer; 2007 Jan; 6():3. PubMed ID: 17214905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory activities of microalgal extracts against Epstein-Barr virus DNA release from lymphoblastoid cells.
    Kok YY; Chu WL; Phang SM; Mohamed SM; Naidu R; Lai PJ; Ling SN; Mak JW; Lim PK; Balraj P; Khoo AS
    J Zhejiang Univ Sci B; 2011 May; 12(5):335-45. PubMed ID: 21528487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
    de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
    HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of penciclovir against Epstein-Barr virus.
    Bacon TH; Boyd MR
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1599-602. PubMed ID: 7492112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.